The regulation of ketogenesis

DW Foster, JD McGarry - Metab. Acidosis, 1982 - books.google.com
DW Foster, JD McGarry
Metab. Acidosis, 1982books.google.com
Ketone bodies accumulate in the plasma in conditions of fasting and uncontrolled diabetes.
The initiating event is a change in the molar ratio of glucagonzinsulin. Insulin deficiency
triggers the lipolytic process in adipose tissue with the result that free fatty acids pass into the
plasma for uptake by liver and other tissues. Glucagon appears to be the primary hormone
involved in the induction of fatty acid oxidation and ketogenesis in the liver. It acts by acutely
dropping hepatic malonyl-CoA concentrations as a consequence of inhibitory effects exerted …
Abstract
Ketone bodies accumulate in the plasma in conditions of fasting and uncontrolled diabetes. The initiating event is a change in the molar ratio of glucagonzinsulin. Insulin deficiency triggers the lipolytic process in adipose tissue with the result that free fatty acids pass into the plasma for uptake by liver and other tissues. Glucagon appears to be the primary hormone involved in the induction of fatty acid oxidation and ketogenesis in the liver. It acts by acutely dropping hepatic malonyl-CoA concentrations as a consequence of inhibitory effects exerted in the glycolytic pathway and on acetyl-CoA carboxylase (EC 6.4. 1.2). The fall in malonyl-CoA concentration activates carnitine acyltransferase I (EC 2.3. 1.21) such that long-chain fatty acids can be transported through the inner mitochondrial membrane to the enzymes of fatty acid oxidation and ketogenesis. The latter are high-capacity systems assuring that fatty acids entering the mitochondria are rapidly oxidized to ketone bodies. Thus, the rate-controlling step for ketogenesis is carnitine acyltransferase I. Administration of food after a fast, or of insulin to the diabetic subject, reduces plasma free fatty acid concentrations, increases the liver concentration of malonyl-CoA, inhibits carnitine acyltransferase I and reverses the ketogenic process.
The ketone bodies and their metabolism are of interest to disparate groups: to the biochemist, who wishes to understand how they are made; to the physiologist, who focuses on their role as alternative fuels; and to the clinician, for whom they represent a threat to life in the patient with uncontrolled, insulin-dependent diabetes (Type I, IDD). The focus of this brief review will be the regulation of ketogenesis. The principles of control appear to be the same in both physiological and pathological conditions; only quantitative differences distinguish the end-states: mild ketosis (after a prolonged fast) or severe metabolic acidosis (in diabetic coma). The hormonal changes involved, the site of regulation and the biochemical mediators implementing activation of ketone synthesis can now be identified with some confidence. A detailed review is available for interested readers (McGarry & Foster 1980a).
books.google.com